CAS No. |
2425675-52-9 |
中文名称 |
NF-κB抑制剂5 |
英文名称 |
NF-κB-IN-5 |
别名 |
Hydrazinecarboxamide, 2-[[(1aR,4E,7aS,10aS,10bR)-1a,2,3,6,7,7a,8,9,10a,10b-decahydro-1a-methyl-8-methylene-9-oxooxireno[9,10]cyclodeca[1,2-b]furan-5-yl]methylene]-N-(4-methylphenyl)-, (2E)-;NF-κB-IN-5 |
标准英文名 |
(E)-2-(((1aR,7aS,10aS,10bR,E)-1a-methyl-8-methylene-9-oxo-1a,2,3,6,7,7a,8,9,10a,10b-decahydrooxireno[2',3':9,10]cyclodeca[1,2-b]furan-5-yl)methylene)-N-(p-tolyl)hydrazine-1-carboxamide |
分子式 |
C23H27N3O4 |
分子量 |
409.49
|
精确分子量 |
409.20
|
SMILES |
O=C(N/N=C/C1=C/CC[C@]2(C)[C@]([C@@]([C@](CC1)([H])C3=C)([H])OC3=O)([H])O2)NC4=CC=C(C)C=C4 |
标准SMILES |
CC1C=CC(=CC=1)NC(=O)NN=CC1CC[C@@H]2[C@H](OC(=O)C2=C)[C@H]2O[C@]2(C)CCC=1 |
用途 |
NF-κB-IN-5 is an orally active NF-κB inhibitor that directly interacts with NF-κB; it exhibits significant antitumor activity against human cancer cell lines (HCT116, U87-MG, HepG2, BGC823, and PC9) with IC50 values of 5.35, 2.81, 2.83, 2.02, and 3.90 μM, respectively; it induces apoptosis in U87-MG tumor cells and causes cell cycle arrest at the G0/G1 phase. |
InChIKey |
DRCZVSOYNQERJP-OFZSZISFSA-N |